Scott Solomon MD — The Blood and ...

Dr. Scott Solomon, MD

Claim this profile

Northside Hospital

Studies Non-Hodgkin's Lymphoma
Studies Acute Lymphoblastic Leukemia
25 reported clinical trials
32 drugs studied

Area of expertise

1

Non-Hodgkin's Lymphoma

Scott Solomon, MD has run 7 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:

CD19 positive
MYC positive
BCL2 positive
2

Acute Lymphoblastic Leukemia

Scott Solomon, MD has run 6 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:

CD19 positive
Philadelphia chromosome positive
MYC positive

Affiliated Hospitals

Image of trial facility.

Northside Hospital

Image of trial facility.

Northside Hospital Cancer Institute

Clinical Trials Scott Solomon, MD is currently running

More about Scott Solomon, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 15 Active Clinical Trials

Treatments Scott Solomon, MD has experience with

  • Fludarabine
  • Cyclophosphamide
  • Ibrutinib
  • Rituximab
  • Lenalidomide
  • Idecabtagene Vicleucel

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Scott Solomon, MD specialize in?

Is Scott Solomon, MD currently recruiting for clinical trials?

Are there any treatments that Scott Solomon, MD has studied deeply?

What is the best way to schedule an appointment with Scott Solomon, MD?

What is the office address of Scott Solomon, MD?

Is there any support for travel costs?